JP2025510700A5 - - Google Patents
Info
- Publication number
- JP2025510700A5 JP2025510700A5 JP2024556005A JP2024556005A JP2025510700A5 JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5 JP 2024556005 A JP2024556005 A JP 2024556005A JP 2024556005 A JP2024556005 A JP 2024556005A JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody conjugate
- linker
- hetero
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22163943 | 2022-03-23 | ||
| EP22163943.8 | 2022-03-23 | ||
| PCT/EP2023/057561 WO2023180485A1 (en) | 2022-03-23 | 2023-03-23 | Antibody-conjugates for targeting of tumours expressing trop-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510700A JP2025510700A (ja) | 2025-04-15 |
| JP2025510700A5 true JP2025510700A5 (cg-RX-API-DMAC10.html) | 2026-03-31 |
Family
ID=81308125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556005A Pending JP2025510700A (ja) | 2022-03-23 | 2023-03-23 | Trop-2を発現する腫瘍を標的化するための抗体コンジュゲート |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250090679A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4496594A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025510700A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20250024743A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119212731A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023241225A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3253220A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL315207A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024011520A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023180485A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3876998A1 (en) | 2018-11-05 | 2021-09-15 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing trop-2 |
| IL315366A (en) | 2022-03-23 | 2024-11-01 | Synaffix Bv | Antibody pairs for targeting PTK7-expressing tumors |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939255A (en) | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| CA2235269C (en) | 1995-10-19 | 2006-09-19 | Bristol-Myers Squibb Company | Monoclonal antibody br110 and uses thereof |
| US9745380B2 (en) | 2002-03-01 | 2017-08-29 | Immunomedics, Inc. | RS7 antibodies |
| CA2478047C (en) | 2002-03-01 | 2014-01-21 | Immunomedics, Inc. | Rs7 antibodies |
| US20070249014A1 (en) | 2006-02-10 | 2007-10-25 | Invitrogen Corporation | Labeling and detection of post translationally modified proteins |
| US7420040B2 (en) | 2006-02-24 | 2008-09-02 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| US20080131428A1 (en) | 2006-02-24 | 2008-06-05 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| WO2009102820A2 (en) | 2008-02-11 | 2009-08-20 | Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services | Modified sugar substrates and methods of use |
| JP2012516887A (ja) | 2009-02-05 | 2012-07-26 | オンコックス・エッセ・エッレ・エッレ | 抗trop−2モノクローナル抗体ならびに腫瘍の治療および診断におけるその使用 |
| WO2011155579A1 (ja) | 2010-06-10 | 2011-12-15 | 北海道公立大学法人札幌医科大学 | 抗Trop-2抗体 |
| SG11201401699WA (en) | 2011-11-11 | 2014-09-26 | Rinat Neuroscience Corp | Antibodies specific for trop-2 and their uses |
| US9427464B2 (en) | 2011-11-22 | 2016-08-30 | Chiome Bioscience Inc. | Anti-human TROP-2 antibody having an antitumor activity in vivo |
| HRP20180268T4 (hr) | 2012-10-23 | 2026-03-27 | Synaffix B.V. | Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu |
| WO2015012904A2 (en) | 2012-12-13 | 2015-01-29 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
| SG10201902571VA (en) | 2013-12-25 | 2019-04-29 | Daiichi Sankyo Co Ltd | Anti-trop2 antibody-drug conjugate |
| EP3177633B1 (en) | 2014-08-04 | 2022-07-20 | SynAffix B.V. | Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof |
| EP3733209A1 (en) | 2014-10-03 | 2020-11-04 | Synaffix B.V. | Sulfamide linker, conjugates thereof, and methods of preparation |
| CN107810273B (zh) | 2015-04-23 | 2022-09-27 | 西纳福克斯股份有限公司 | 用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法 |
| CA3026651A1 (en) | 2016-06-09 | 2017-12-14 | Blinkbio, Inc. | Silanol based therapeutic payloads |
| TWI920652B (zh) | 2018-06-07 | 2026-04-01 | 美商思進公司 | 喜樹鹼結合物 |
| EP3876998A1 (en) * | 2018-11-05 | 2021-09-15 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing trop-2 |
| KR20240104214A (ko) | 2019-03-29 | 2024-07-04 | 메디뮨 리미티드 | 화합물 및 이의 접합체 |
| RS64961B1 (sr) | 2019-04-26 | 2024-01-31 | Immunogen Inc | Derivati kamptotecina |
| KR20230021018A (ko) | 2020-06-05 | 2023-02-13 | 재단법인 생물기술개발중심 | 항-메조텔린 항체를 함유하는 항체-약물 컨쥬게이트 및 이의 용도 |
| NL2026947B1 (en) | 2020-11-20 | 2022-07-01 | Synaffix Bv | Tyrosine-based antibody conjugates |
| CN113816969B (zh) | 2021-04-30 | 2024-01-16 | 联宁(苏州)生物制药有限公司 | 依喜替康类化合物、其抗体药物偶联物及其应用 |
| US12533419B2 (en) | 2021-07-19 | 2026-01-27 | Mabplex International Co., Ltd. | Antibody drug conjugate loaded with binary toxins and its application |
-
2023
- 2023-03-23 CA CA3253220A patent/CA3253220A1/en active Pending
- 2023-03-23 AU AU2023241225A patent/AU2023241225A1/en active Pending
- 2023-03-23 EP EP23714682.4A patent/EP4496594A1/en active Pending
- 2023-03-23 WO PCT/EP2023/057561 patent/WO2023180485A1/en not_active Ceased
- 2023-03-23 JP JP2024556005A patent/JP2025510700A/ja active Pending
- 2023-03-23 CN CN202380028866.0A patent/CN119212731A/zh active Pending
- 2023-03-23 KR KR1020247034725A patent/KR20250024743A/ko active Pending
- 2023-03-23 IL IL315207A patent/IL315207A/en unknown
-
2024
- 2024-09-19 MX MX2024011520A patent/MX2024011520A/es unknown
- 2024-09-20 US US18/892,270 patent/US20250090679A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chittaboina et al. | One-pot synthesis of triazole-linked glycoconjugates | |
| US20090181402A1 (en) | Compositions and methods for coupling a plurality of compounds to a scaffold | |
| US10030066B2 (en) | Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor | |
| JP2020000252A5 (cg-RX-API-DMAC10.html) | ||
| JP2020114818A5 (cg-RX-API-DMAC10.html) | ||
| JP5825507B2 (ja) | 分岐型ヘテロポリエチレングリコール | |
| FI89172B (fi) | Nya oligosackarider och deras anvaendning foer framstaellning av immunogener | |
| AU2013237497B2 (en) | Carbohydrate-glycolipid conjugate vaccines | |
| EP2121030A2 (en) | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | |
| US20200261560A1 (en) | Precision glycoconjugates as therapeutic tools | |
| US20120322955A1 (en) | Polyoxyethylene derivative having plural hydroxyl groups at terminal end thereof | |
| US9365598B2 (en) | Phosphine derivatives of fluorescent compounds | |
| JP2025510623A5 (cg-RX-API-DMAC10.html) | ||
| JP2025510678A5 (cg-RX-API-DMAC10.html) | ||
| WO2026016269A1 (zh) | 一种用于主动靶向表皮生长因子受体检测的近红外荧光探针及其制备方法与应用 | |
| JP5612467B2 (ja) | Fmocをベースとした加水分解性リンカーの調製方法 | |
| JP2015157946A (ja) | 分岐型ヘテロポリエチレングリコールおよび中間体 | |
| JP2908558B2 (ja) | 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法 | |
| US20240000964A1 (en) | Compound or salt thereof, and antibody obtained by using the same | |
| WO2023180485A1 (en) | Antibody-conjugates for targeting of tumours expressing trop-2 | |
| JP2012502011A5 (cg-RX-API-DMAC10.html) | ||
| JP2001510853A (ja) | ポリエーテルホスフェートの製造方法 | |
| US20080220005A1 (en) | Comb Polymers | |
| CN1742057A (zh) | 用于荧光诊断的亲水性硫醇反应性花青染料及其与生物分子的缀合物 | |
| KR20230157983A (ko) | 당사슬 및 당사슬을 포함하는 의약품의 제조 방법 |